Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
复制标题

临床脓毒症和实验性内毒素血症中肿瘤坏死因子可溶性受体的释放。

DOI:
--
复制
发表时间:
1993
影响因子:
6.4
通讯作者:
S. Deventer
S. Deventer
中科院分区:
医学2区
文献类型:
--
作者:
T. Poll;J. Jansen;Diana van Leenen;Marijke von der Mohlen;M. Levi;H. Cate;H. Gallati;J. Cate;S. Deventer

文献摘要

参考文献

被引文献

相似文献

为了评估肿瘤坏死因子(TNF)在可溶性TNF受体(sTNFRs)出现中的作用,研究了20例临床诊断为脓毒症的连续患者,以及7只黑猩猩在给予内毒素(4 ng/kg)(含或不含戊茶碱)后的情况。与健康对照组相比,患者血清sTNFR-p55和sTNFR-p75水平显著升高(两种受体均P <0.0001)。两种可溶性受体的水平与同时测量的免疫反应性TNF浓度相关(p55:r = 0.63,P <0.01; p75:r = 0.69,P <0.001)。在黑猩猩中,内毒素诱导随后的血清TNF和sTNFRs浓度升高。尽管喷替福林将TNF对静脉内毒素的反应降低至20%(P <0.05),但sTNFR的出现仅受到中度抑制(sTNFR-p55平均降低至79%,P <0.05; sTNFR-p75平均降低至77%,P = 0.12)。这些结果表明,TNF或者在全身感染中sTNFR的出现中不起重要作用,或者在一些细菌攻击后少量TNF残留在循环中足以保持其可溶性受体的分泌。
To assess the role of tumor necrosis factor (TNF) in the appearance of soluble TNF receptors (sTNFRs), 20 consecutive patients with a clinical diagnosis of sepsis were studied as were 7 chimpanzees after administration of endotoxin (4 ng/kg) with or without pentoxifylline. The patients had markedly elevated serum levels of sTNFR-p55 and sTNFR-p75 compared with healthy controls (P < .0001 for both receptors). The levels of both soluble receptors correlated with simultaneously measured immunoreactive TNF concentrations (p55: r = .63, P < .01; p75: r = .69, P < .001). In the chimpanzees, endotoxin induced subsequent rises in the serum concentrations of TNF and sTNFRs. Although pentoxifylline reduced the TNF response to intravenous endotoxin to 20% (P < .05), the appearance of sTNFRs was only moderately inhibited (sTNFR-p55 to 79% on average, P < .05; sTNFR-p75 to 77%, P = .12). These results indicate that TNF either does not play an important role in the appearance of sTNFRs in systemic infection or that a small amount of TNF remaining in the circulation after some bacterial challenges is sufficient to preserve the secretion of its soluble receptors.